LifeTech Scientific Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	71.91	222.39	263.24	325.34	292.47	216.09
Depreciation & Amortization	87.83	86.86	75.31	66.08	61.46	61.84
Other Amortization	1.14	1.14	1.85	1.03	0.6	0.79
Loss (Gain) From Sale of Assets	0.53	0.53	0.06	0.34	-0.06	-5.93
Asset Writedown & Restructuring Costs	65.97	65.97	-	21.31	-	-
Loss (Gain) From Sale of Investments	-38.45	-38.45	177.96	35.23	51.08	-199.53
Loss (Gain) on Equity Investments	0.66	0.66	1.96	1.77	0.87	2.82
Stock-Based Compensation	133.38	133.38	112.84	62.72	19.73	153.98
Provision & Write-off of Bad Debts	3.04	3.04	-0.85	1.91	-8.51	7.81
Other Operating Activities	308.29	-129.82	-196.46	-62.53	-91.95	34.22
Change in Accounts Receivable	31.86	31.86	98.97	-18.34	56.68	16.85
Change in Inventory	-61.28	-61.28	-248.46	-112.71	-31.36	-4.74
Change in Accounts Payable	-2.17	-2.17	119.14	94.41	114.26	42.21
Change in Unearned Revenue	22.72	22.72	7.16	19.38	9.78	14.31
Change in Other Net Operating Assets	-15.37	-15.37	5.34	-47.61	-33.95	-2.19
Operating Cash Flow	610.06	321.46	418.05	388.32	441.09	338.53
Operating Cash Flow Growth	105.00%	-23.11%	7.66%	-11.96%	30.30%	23.11%
Capital Expenditures	-37.23	-196.64	-200.83	-226.37	-275.82	-105.07
Sale of Property, Plant & Equipment	0.44	0.44	0.55	1.88	0.5	2.17
Cash Acquisitions	-10.1	-6.77	-	-	-	-
Sale (Purchase) of Intangibles	-85.05	-86.37	-91.86	-109.1	-67.46	-53.31
Investment in Securities	-470.21	-261.96	-190.4	-161.17	127.65	-180.6
Other Investing Activities	35.91	33.76	28.65	36.3	176.14	-4.81
Investing Cash Flow	-566.23	-517.54	-453.88	-458.47	-39	-341.63
Short-Term Debt Issued	-	99	-	-	-	-
Long-Term Debt Issued	-	-	-	-	67.5	198.68
Total Debt Issued	-	99	-	-	67.5	198.68
Short-Term Debt Repaid	-	-99	-	-	-	-
Long-Term Debt Repaid	-	-7.07	-9.31	-12.47	-185.9	-329.89
Total Debt Repaid	-103.62	-106.07	-9.31	-12.47	-185.9	-329.89
Net Debt Issued (Repaid)	-103.62	-7.07	-9.31	-12.47	-118.4	-131.21
Issuance of Common Stock	1.62	0.51	207.27	65.39	17.84	816.03
Repurchase of Common Stock	-0	-146.64	-26.03	-268.29	-170.52	-
Other Financing Activities	9.16	36.24	10.78	0.16	14.7	-10.16
Financing Cash Flow	-92.84	-116.97	182.71	-215.2	-256.38	674.67
Foreign Exchange Rate Adjustments	-0.96	-0.52	-1.36	-0.12	1.86	1.09
Net Cash Flow	-49.97	-313.56	145.52	-285.47	147.58	672.66
Free Cash Flow	572.84	124.83	217.22	161.95	165.27	233.46
Free Cash Flow Growth	3681.34%	-42.54%	34.13%	-2.01%	-29.21%	6.90%
Free Cash Flow Margin	43.15%	9.57%	17.14%	14.76%	17.86%	36.35%
Free Cash Flow Per Share	0.13	0.03	0.05	0.04	0.04	0.05
Cash Interest Paid	1.14	1.89	0.72	0.63	2.61	25.69
Cash Income Tax Paid	54.42	78.35	80.41	71.11	59.68	43.72
Levered Free Cash Flow	539.54	15.81	-202.65	-68.71	165.52	34.2
Unlevered Free Cash Flow	540.25	16.99	-202.2	-68.31	167.15	50.26
Change in Working Capital	-24.23	-24.23	-17.86	-64.87	115.41	66.45

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.